Daniel Forss - Vitrolife VP Consumables

VITR Stock  SEK 228.60  7.20  3.25%   

Insider

Daniel Forss is VP Consumables of Vitrolife AB
Age 51
Phone46 3 17 21 80 00
Webhttps://www.vitrolife.com

Vitrolife Management Efficiency

The company has return on total asset (ROA) of 0.0205 % which means that it generated a profit of $0.0205 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0246 %, meaning that it generated $0.0246 on every $100 dollars invested by stockholders. Vitrolife's management efficiency ratios could be used to measure how well Vitrolife manages its routine affairs as well as how well it operates its assets and liabilities.
Vitrolife AB has accumulated 2.03 B in total debt with debt to equity ratio (D/E) of 4.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vitrolife AB has a current ratio of 4.69, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Vitrolife until it has trouble settling it off, either with new capital or with free cash flow. So, Vitrolife's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vitrolife AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vitrolife to invest in growth at high rates of return. When we think about Vitrolife's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Svante HedinSkandinaviska Enskilda Banken
N/A
Torun LitzenKinnevik Investment AB
56
Freya SunNordic Asia Investment
N/A
Anna StenbergKinnevik Investment AB
44
Catarina ForsgrenAxfood AB
N/A
Jeanette AlmbergSkandinaviska Enskilda Banken
58
sa DomeijAxfood AB
61
Masih YazdiSkandinaviska Enskilda Banken
43
Ainar LeppnenSkandinaviska Enskilda Banken
51
Emil SallnsViva Wine Group
52
Yu ZhangNordic Asia Investment
N/A
Birna KradttirArion banki hf
45
Alexander BergendorfAxfood AB
N/A
Olafur HoskuldssonArion banki hf
42
Andreas BernstromKinnevik Investment AB
49
Linn GfvertViva Wine Group
42
James EwingInvisio Communications AB
N/A
Anna MollerViva Wine Group
N/A
Stefan PeturssonArion banki hf
60
Yu JianNordic Asia Investment
N/A
Bengt AnderssonAxfood AB
N/A
Vitrolife AB , a medical device company, develops, produces, and markets products for assisted reproduction. Vitrolife AB was founded in 1981 and is headquartered in Gothenburg, Sweden. Vitrolife operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 415 people. Vitrolife AB (VITR) is traded on Stockholm Exchange in Sweden and employs 1,073 people.

Management Performance

Vitrolife AB Leadership Team

Elected by the shareholders, the Vitrolife's board of directors comprises two types of representatives: Vitrolife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vitrolife. The board's role is to monitor Vitrolife's management team and ensure that shareholders' interests are well served. Vitrolife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vitrolife's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rickard Ericsson, Vice President Market Region EMEA & Americas
Daniel Forss, VP Consumables
Claus Bisgaard, VP Technologies
Ricardo Capella, VP Services
Karin Russberg, VP Sustainability
Patrik Tolf, Chief Officer
Thomas MSc, Pres CEO

Vitrolife Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Vitrolife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vitrolife Stock Analysis

When running Vitrolife's price analysis, check to measure Vitrolife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitrolife is operating at the current time. Most of Vitrolife's value examination focuses on studying past and present price action to predict the probability of Vitrolife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitrolife's price. Additionally, you may evaluate how the addition of Vitrolife to your portfolios can decrease your overall portfolio volatility.